MS Speaks
Multiple Sclerosis => MS - RESEARCH AND NEWS => Topic started by: agate on September 22, 2020, 08:04:07 pm
-
From Multiple Sclerosis Journal (September 17, 2020), "The risk of infections in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement":
https://journals.sagepub.com/doi/abs/10.1177/1352458520952311
Delphi method:
https://en.wikipedia.org/wiki/Delphi_method
We don't really find out from the abstract just what was concluded but nonetheless this abstract does show that infections in MS are a continuing concern, in relation to the disease-modifying therapies.